Orders from 120 EUR Free delivery from 250 EUR Ready for pickup dead drop: collect in 5 min

Substances · Phenethylamine derivatives

6-MAPB

C12H15NO CAS 1354631-79-0 Analytical reference material — not for human consumption
Preferred name
6-MAPB
IUPAC name
1-(1-benzofuran-6-yl)-N-methylpropan-2-amine
Parent CAS number (reference)
1354631-79-0
Molecular formula
C12H15NO
Molecular weight
189.25 g/mol
InChIKey
QLAAURQYEAEHBO-UHFFFAOYSA-N
PubChem
CID 122202866
Source
PubChem
Verified synonyms & catalog abbreviations
6-(2-Methylaminopropyl)benzofuran 6MAPB 6 MAPB

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

6-MAPB

Entactogen (serotonin releaser) 6-Substituted benzofuran (N-methyl)
Verified PubChem & CAS Identity C12H15NO · CAS 1354631-79-0 · CID 122202866
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 189.25 g/mol
Peer-Reviewed & Agency Citations 3 · verified sources

Receptor Telemetry & Mechanism of Action

DAT Dopaminergic Signaling Primary
NET Noradrenergic Signaling Active
SERT Serotonergic Signaling Variable

6-MAPB is the N-methyl analogue of 6-APB, in the same structural relationship as MDMA to MDA or 5-MAPB to 5-APB. It is a serotonin-leaning entactogen, generally described as smoother and less stimulating than 6-APB, with the same rule against stacking other releasers. 5-HT2B agonism remains relevant for the benzofuran class when use is repeated. PsychonautWiki does not publish a standalone dose table for 6-MAPB; the oral bands below are the TripSit light/common/strong/heavy figures.

Biotransformation & Active Metabolites

Not a prodrug of 6-APB or MDMA. The freebase parent is C12H15NO, 189.25 g/mol, the same formula and mass as 5-MAPB (CAS 1354631-77-8) and a different CAS (1354631-79-0). Position 5 versus position 6 is the identity, not the molecular weight. Salt form still changes the weighed mass.

Temporal Pharmacokinetics

Smoother, less stimulating entactogen than 6-APB, still serotonergic, with a long tail and a flat next day.

  1. Onset 30–60 minutes (aligned with oral 6-APB; a separate 6-MAPB onset table is not on PsychonautWiki)
  2. Peak Window several hours inside a 5–10 hour total
  3. Total Window 5–10 hours (TripSit / secondary oral summaries)
  4. Residual / Half-Life After-effects 2–4 hours at minimum, with a serotonergic low mood that can last longer, as with 5-MAPB and 6-APB. Human half-life is not established.

TripSit oral light 20–40 mg, common 40–80 mg, strong 80–100 mg, heavy above 100 mg. A threshold just under the light band is about 15–20 mg. The common band is wide. 80 mg is already the top of common and the start of strong. Do not import the 6-APB strong band (90–120 mg) or the 5-MAPB hydrochloride adjustment onto this name without knowing the salt.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
15–20 mg
Cognitive & Sensory

A mild mood change at the bottom edge of the TripSit light band.

Somatic & Autonomic

Slight body warmth.

Light
20–40 mg
Cognitive & Sensory

Gentle empathy and calm stimulation.

Somatic & Autonomic

Jaw awareness, reduced appetite, and mild pupil dilation.

Common Reference
40–80 mg
Cognitive & Sensory

Clear entactogenic warmth, tactile enhancement, and less psychedelic overlay than 6-APB.

Somatic & Autonomic

Bruxism, sweating, and a moderate rise in heart rate.

Strong
80–100 mg
Cognitive & Sensory

Intense emotional openness with growing anxiety or restlessness and little extra benefit.

Somatic & Autonomic

Stronger cardiovascular load, nausea, and hyperthermia risk.

Heavy / Toxic Zone
100 mg+
Cognitive & Sensory

Overwhelmed and toxic rather than pleasantly empathic.

Somatic & Autonomic

Hyperthermia, hypertension, and serotonin toxicity if MDMA, 5-MAPB, or 4-FA is added.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

MAOIs (phenelzine, tranylcypromine, moclobemide, harmala alkaloids)

Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.

MDMA, 5-MAPB, 6-APB, 4-FA, and other serotonin releasers

6-MAPB is itself a serotonin releaser. Combinations are serotonin-syndrome and hyperthermia combinations.

Tramadol and DXM

Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.

Elevated Hazard — Avoid

Stimulants and 25x-NBOMe

Added cardiovascular strain and seizure risk.

Alcohol

Dehydration and poor judgment across a 5–10 hour course.

Caution / Receptor Attenuation

SSRIs

Blunt warmth without removing risk from a second releaser.

5-MAPB weighed as if the shared formula made them identical

Both are C12H15NO, 189.25 g/mol. CAS 1354631-79-0 is 6-MAPB. CAS 1354631-77-8 is 5-MAPB. Their oral common bands are not the same document.

Structural Isomer & Sibling Comparison

6-MAPB is the N-methyl, 6-position entactogen. TripSit common oral is 40–80 mg, versus PsychonautWiki 60–90 mg for 6-APB and 60–80 mg for 5-MAPB. It is usually less stimulating and less visual than 6-APB and a bit less 'classic MDMA' than 5-MAPB. The shared formula with 5-MAPB is an identity trap, the same kind as 3-FA versus 4-FA. 5-HT2B caution and the ban on stacked releasers apply to all three.

Physicochemical Stability & Storage

Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.

Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.

Cross-Tolerance & Dependence Profile

Serotonergic tolerance and cross-tolerance with MDMA, 5-MAPB, and 6-APB. Because PsychonautWiki gives 6-APB a multi-week reset, 6-MAPB should be spaced in that same way rather than treated as a milder drug that can be repeated sooner. The crash is fatigue and low mood. repeated exposure across the wide 40–80 mg common band is how people arrive at 100 mg without planning to.

Chemical Architecture & Structural Profile

6-MAPB (1-(1-benzofuran-6-yl)-N-methylpropan-2-amine) is a reference compound belonging to the Phenethylamine derivatives class, characterized by the molecular formula C12H15NO and a molar mass of 189.25 g/mol. The parent molecule is indexed under CAS registry number 1354631-79-0 and in the NCBI PubChem database as CID 122202866 (Standard InChIKey: QLAAURQYEAEHBO-UHFFFAOYSA-N). This molecule shares its empirical formula (C12H15NO) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (1354631-79-0), and spectroscopic profile.

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 6-MAPB is indexed within the Phenethylamine derivatives structural group. Substituted phenethylamine derivative; documented reference precautions highlight hazardous interactions with MAOIs, tramadol, and lithium salts. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations